Canada's Drug Agency (CDA) found that expenditure on injectable semaglutide, under the brand-name Ozempic, increased from $13.5 million in 2019 to $227 million in 2021, with 20% of the claims being for non-type 2 diabetes use
Typically, one liquid facelift treatment can provide noticeable results, although touch-up sessions may be recommended depending on your aesthetic goals
A study in Tokyo involving patients with acute alcohol intoxication titled Effect of intravenous fluid therapy for acute alcohol intoxication on length of time from arrival at the emergency department until awakening by Takero Terayama, et al., 2023, found that routine IV fluid therapy did not significantly reduce the time until awakening

Seven drugs have currently been approved for the treatment of Type 2 diabetes mellitus, including short-acting agents like exenatide and lixisenatide, as well as long-acting injectable agents such as albiglutide, dulaglutide, liraglutide, and semaglutide. GLP-1s regulate lipid metabolism, reducing the effects of hyperlipidemia and helping to lower the risk for both chronic kidney disease (CKD) and diabetic kidney disease. They have also been shown to reduce oxidative stress, which includes stimulating glomerular filtration and reducing vasoconstriction, slowing the progression of CKD. Limited data from clinical trials have been published on the effects of GLP-1 receptor agonists in individuals with post-liver transplant diabetes mellitus (PTDM)
See the weight loss numbers, mechanism differences, dosing schedules, and which drug may fit your situation